Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

588 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Targeting AMPK: a new therapeutic opportunity in breast cancer.
Hadad SM, Fleming S, Thompson AM. Hadad SM, et al. Among authors: thompson am. Crit Rev Oncol Hematol. 2008 Jul;67(1):1-7. doi: 10.1016/j.critrevonc.2008.01.007. Epub 2008 Mar 14. Crit Rev Oncol Hematol. 2008. PMID: 18343152 Review.
PS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancer.
Thompson AM, Elton RA, Hawkins RA, Chetty U, Steel CM. Thompson AM, et al. Br J Cancer. 1998;77(3):492-6. doi: 10.1038/bjc.1998.78. Br J Cancer. 1998. PMID: 9472649 Free PMC article.
Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.
Thompson AM, Crichton DN, Elton RA, Clay MF, Chetty U, Steel CM. Thompson AM, et al. Br J Cancer. 1998 Mar;77(5):797-800. doi: 10.1038/bjc.1998.129. Br J Cancer. 1998. PMID: 9514060 Free PMC article.
An immunochemical analysis of mdm2 expression in human breast cancer and the identification of a growth-regulated cross-reacting species p170.
O'Neill M, Campbell SJ, Save V, Thompson AM, Hall PA. O'Neill M, et al. Among authors: thompson am. J Pathol. 1998 Nov;186(3):254-61. doi: 10.1002/(SICI)1096-9896(1998110)186:3<254::AID-PATH185>3.0.CO;2-U. J Pathol. 1998. PMID: 10211113
Dephosphorylation of p53 at Ser20 after cellular exposure to low levels of non-ionizing radiation.
Craig AL, Blaydes JP, Burch LR, Thompson AM, Hupp TR. Craig AL, et al. Among authors: thompson am. Oncogene. 1999 Nov 4;18(46):6305-12. doi: 10.1038/sj.onc.1203085. Oncogene. 1999. PMID: 10597229
Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer.
Lücke CD, Philpott A, Metcalfe JC, Thompson AM, Hughes-Davies L, Kemp PR, Hesketh R. Lücke CD, et al. Among authors: thompson am. Cancer Res. 2001 Jan 15;61(2):482-5. Cancer Res. 2001. PMID: 11212236
Differential p53 protein expression in breast cancer fine needle aspirates: the potential for in vivo monitoring.
Ball HM, Hupp TR, Ziyaie D, Purdie CA, Kernohan NM, Thompson AM. Ball HM, et al. Among authors: thompson am. Br J Cancer. 2001 Oct 19;85(8):1102-5. doi: 10.1054/bjoc.2001.2064. Br J Cancer. 2001. PMID: 11710820 Free PMC article.
Immediate versus delayed free TRAM breast reconstruction: an analysis of perioperative factors and complications.
DeBono R, Thompson A, Stevenson JH. DeBono R, et al. Br J Plast Surg. 2002 Mar;55(2):111-6. doi: 10.1054/bjps.2002.3747. Br J Plast Surg. 2002. PMID: 11987942
P53 and breast cancer.
Ziyaie D, Hupp TR, Thompson AM. Ziyaie D, et al. Among authors: thompson am. Breast. 2000 Oct;9(5):239-46. doi: 10.1054/brst.2000.0199. Breast. 2000. PMID: 14732173
Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo.
Spruce BA, Campbell LA, McTavish N, Cooper MA, Appleyard MV, O'Neill M, Howie J, Samson J, Watt S, Murray K, McLean D, Leslie NR, Safrany ST, Ferguson MJ, Peters JA, Prescott AR, Box G, Hayes A, Nutley B, Raynaud F, Downes CP, Lambert JJ, Thompson AM, Eccles S. Spruce BA, et al. Among authors: thompson am. Cancer Res. 2004 Jul 15;64(14):4875-86. doi: 10.1158/0008-5472.CAN-03-3180. Cancer Res. 2004. PMID: 15256458
588 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback